My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 171

    1.

    A cost analysis of diabetic lower-extremity ulcers.

    Harrington C, Zagari MJ, Corea J, Klitenic J.

    Diabetes Care. 2000 Sep;23(9):1333-8.PMID: 10977028 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Costs of lower-extremity ulcers among patients with diabetes.

    Stockl K, Vanderplas A, Tafesse E, Chang E.

    Diabetes Care. 2004 Sep;27(9):2129-34.PMID: 15333473 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cost-effective management of recalcitrant diabetic foot ulcers.

    Albert S.

    Clin Podiatr Med Surg. 2002 Oct;19(4):483-91. Review.PMID: 12471856 [PubMed - indexed for MEDLINE]Related articles

    4.

    Potential economic benefits of lower-extremity amputation prevention strategies in diabetes.

    Ollendorf DA, Kotsanos JG, Wishner WJ, Friedman M, Cooper T, Bittoni M, Oster G.

    Diabetes Care. 1998 Aug;21(8):1240-5.PMID: 9702427 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data.

    Persson U, Willis M, Odegaard K, Apelqvist J.

    Value Health. 2000 Nov-Dec;3 Suppl 1:39-46.PMID: 16464208 [PubMed - indexed for MEDLINE]Related articles

    6.

    Costs and duration of care for lower extremity ulcers in patients with diabetes.

    Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M.

    Clin Ther. 1998 Jan-Feb;20(1):169-81. Erratum in: Clin Ther 1998 Mar-Apr;20(2):373. PMID: 9522113 [PubMed - indexed for MEDLINE]Related articles

    7.

    What is the most effective way to reduce incidence of amputation in the diabetic foot?

    Apelqvist J, Larsson J.

    Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S75-83. Review.PMID: 11054894 [PubMed - indexed for MEDLINE]Related articles

    8.

    Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation.

    Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J.

    J Intern Med. 1994 May;235(5):463-71.PMID: 8182403 [PubMed - indexed for MEDLINE]Related articles

    9.

    Negative-pressure wound therapy and diabetic foot amputations: a retrospective study of payer claims data.

    Frykberg RG, Williams DV.

    J Am Podiatr Med Assoc. 2007 Sep-Oct;97(5):351-9.PMID: 17901338 [PubMed - indexed for MEDLINE]Related articles

    10.

    M.A.I.D.: a prognostic score estimating probability of healing in chronic lower extremity wounds.

    Beckert S, Pietsch AM, Küper M, Wicke C, Witte M, Königsrainer A, Coerper S.

    Ann Surg. 2009 Apr;249(4):677-81.PMID: 19300218 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations.

    Ragnarson Tennvall G, Apelqvist J.

    Diabetologia. 2001 Nov;44(11):2077-87.PMID: 11719840 [PubMed - indexed for MEDLINE]Related articles

    12.

    The health care costs of diabetic peripheral neuropathy in the US.

    Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA.

    Diabetes Care. 2003 Jun;26(6):1790-5.PMID: 12766111 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

    Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH.

    Diabetes Care. 1999 Mar;22(3):382-7.PMID: 10097914 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Scottish foot ulcer risk score predicts foot ulcer healing in a regional specialist foot clinic.

    Leese G, Schofield C, McMurray B, Libby G, Golden J, MacAlpine R, Cunningham S, Morris A, Flett M, Griffiths G.

    Diabetes Care. 2007 Aug;30(8):2064-9. Epub 2007 May 22.PMID: 17519428 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.

    O'Meara S, Cullum N, Majid M, Sheldon T.

    Health Technol Assess. 2000;4(21):1-237. Review.PMID: 11074391 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis.

    Kantor J, Margolis DJ.

    Dermatol Surg. 2001 Apr;27(4):347-51.PMID: 11298704 [PubMed - indexed for MEDLINE]Related articles

    17.

    The case for evidence in wound care: investigating advanced treatment modalities in healing chronic diabetic lower extremity wounds.

    Lyon KC.

    J Wound Ostomy Continence Nurs. 2008 Nov-Dec;35(6):585-90.PMID: 19018198 [PubMed - indexed for MEDLINE]Related articles

    18.

    Economic costs of diabetes in the US in 2002.

    Hogan P, Dall T, Nikolov P; American Diabetes Association.

    Diabetes Care. 2003 Mar;26(3):917-32.PMID: 12610059 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countries.

    Ghatnekar O, Persson U, Willis M, Odegaard K.

    Pharmacoeconomics. 2001;19(7):767-78.PMID: 11548912 [PubMed - indexed for MEDLINE]Related articles

    20.

    Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population.

    Wrobel JS, Mayfield JA, Reiber GE.

    Diabetes Care. 2001 May;24(5):860-4.PMID: 11347744 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity